Small Business Funding for Innovations in Alzheimer’s Disease and Aging

Share on Social Media

The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. The NIA Small Business Program is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2022
Current Funding Opportunities

All applicants should consider submitting through the Omnibus Solicitation, which covers a broad range of NIA research topics and investigator-initiated ideas. For small businesses and research organizations working on solutions for Alzheimer’s disease (AD) and AD-related dementias (ADRD), NIA has targeted solicitations for SBIR and STTR that allow for higher budget limits of up to $500,000 for Phase I and $2.5 million for Phase II. These opportunities are part of NIA’s unprecedented research and development budget to develop AD/ADRD interventions and therapeutics. 

The following opportunities are currently open:2021 NIH SBIR Omnibus Solicitation – Clinical Trial Required SBIR (PA-21-260)STTR (PA-21-261)2021 NIH SBIR Omnibus Solicitation – Clinical Trial Not AllowedSBIR (PA-21-259)STTR (PA-21-262)Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD)SBIR (PAS-19-316)STTR (PAS-19-317)Commercialization Readiness Pilot (CRP) Program: SBIR & STTR PA-20-128 (SB1, Technical Assistance) — Clinical Trial Not AllowedSBIR & STTR PA-20-129 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Not AllowedSBIR & STTR PA-20-130 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Required For a list of NIA SBIR and STTR funding opportunities, deadlines, and budget limits, visit the NIA Small Business Program funding page. 

Latest News

Introducing The New FlowMaxx Pro

Introducing The New FlowMaxx Pro

Smithfield, RI – High Purity New England (HPNE), a leading supplier of solutions for the biopharma industry, has launched the new FlowMaxx Pro, a completely redesigned version of their best-selling Quaternary Diaphragm Smart Pump. The highly-anticipated launch of...

Biotech Industry News